-
Something wrong with this record ?
Prognostic role of c-Met in head and neck squamous cell cancer tissues: a meta-analysis
V. Vsiansky, J. Gumulec, M. Raudenska, M. Masarik,
Language English Country Great Britain
Document type Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't
Grant support
16-29835A
Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic) - International
16-29835A
Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic) - International
NV16-29835A
MZ0
CEP Register
Digital library NLK
Full text - Article
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
Nature Open Access
from 2011-12-01
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
Springer Nature OA/Free Journals
from 2011-12-01
- MeSH
- Survival Analysis MeSH
- Squamous Cell Carcinoma of Head and Neck diagnosis mortality pathology MeSH
- Humans MeSH
- Lymphatic Metastasis MeSH
- Prognosis MeSH
- Proto-Oncogene Proteins c-met metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Meta-Analysis MeSH
- Research Support, Non-U.S. Gov't MeSH
This meta-analysis aims to evaluate the effects of high c-Met levels in head and neck squamous cell carcinomas (HNSCC) on survival and clinicopathological features. Publications concerned with the clinical significance of c-Met protein expression in HNSCC were identified from the Scopus and Web of Science database searches. To elucidate the relationship between c-Met expression and clinical outcomes, a meta-analysis of the selected articles was conducted. Seventeen publications involving a total of 1724 patients met the inclusion criteria. c-Met overexpression was significantly correlated with poor overall survival (hazard ratio (HR) = 2.19, 95% confidence interval (CI) = 1.55-3.10). c-Met immunohistochemical staining positivity was also associated with worse relapse-free survival (HR = 1.64, 95% CI = 1.24-2.17) and presence of regional lymph node metastases (odds ratio (OR) = 1.76, 95% CI = 1.26-2.45). High levels of c-Met expression in HNSCC predict unfavorable prognosis associated with common clinicopathological features.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045380
- 003
- CZ-PrNML
- 005
- 20200113082127.0
- 007
- ta
- 008
- 200109s2018 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-018-28672-8 $2 doi
- 035 __
- $a (PubMed)29991692
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Vsiansky, Vit $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.
- 245 10
- $a Prognostic role of c-Met in head and neck squamous cell cancer tissues: a meta-analysis / $c V. Vsiansky, J. Gumulec, M. Raudenska, M. Masarik,
- 520 9_
- $a This meta-analysis aims to evaluate the effects of high c-Met levels in head and neck squamous cell carcinomas (HNSCC) on survival and clinicopathological features. Publications concerned with the clinical significance of c-Met protein expression in HNSCC were identified from the Scopus and Web of Science database searches. To elucidate the relationship between c-Met expression and clinical outcomes, a meta-analysis of the selected articles was conducted. Seventeen publications involving a total of 1724 patients met the inclusion criteria. c-Met overexpression was significantly correlated with poor overall survival (hazard ratio (HR) = 2.19, 95% confidence interval (CI) = 1.55-3.10). c-Met immunohistochemical staining positivity was also associated with worse relapse-free survival (HR = 1.64, 95% CI = 1.24-2.17) and presence of regional lymph node metastases (odds ratio (OR) = 1.76, 95% CI = 1.26-2.45). High levels of c-Met expression in HNSCC predict unfavorable prognosis associated with common clinicopathological features.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lymfatické metastázy $7 D008207
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a protoonkogenní proteiny c-met $x metabolismus $7 D019859
- 650 _2
- $a dlaždicobuněčné karcinomy hlavy a krku $x diagnóza $x mortalita $x patologie $7 D000077195
- 650 _2
- $a analýza přežití $7 D016019
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a metaanalýza $7 D017418
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Gumulec, Jaromir $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. j.gumulec@med.muni.cz. Department of Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. j.gumulec@med.muni.cz.
- 700 1_
- $a Raudenska, Martina $u Department of Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.
- 700 1_
- $a Masarik, Michal $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. Department of Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. First Faculty of Medicine and BIOCEV, Charles University, Katerinska 32, 121 08, Prague 2, Czech Republic.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 8, č. 1 (2018), s. 10370
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29991692 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200113082458 $b ABA008
- 999 __
- $a ok $b bmc $g 1483649 $s 1084053
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 8 $c 1 $d 10370 $e 20180710 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- GRA __
- $a 16-29835A $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic) $2 International
- GRA __
- $a 16-29835A $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic) $2 International
- GRA __
- $a NV16-29835A $p MZ0
- LZP __
- $a Pubmed-20200109